| Tag | Content |
|---|
EnhancerAtlas ID | HS091-23478 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr19:16254580-16255580 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFAT5 | MA0606.1 | chr19:16254744-16254754 | AATGGAAAAT | - | 6.02 | | NFATC1 | MA0624.1 | chr19:16254744-16254754 | AATGGAAAAT | - | 6.02 | | NFATC3 | MA0625.1 | chr19:16254744-16254754 | AATGGAAAAT | - | 6.02 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_09640 | chr19:16251336-16262834 | CD14 | | SE_44018 | chr19:16253563-16258783 | MM1S | | SE_67337 | chr19:16253563-16258783 | MM1S |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | CCAGGTATGT GACCCAAGAG CCTCAGCCCT CGAGGAGACA GAACGTGGGG GCTGGGCTAG 60
GCCAGAAGGA GGGACAGGGC TAGTGGGGCC TGGGGTGGCA GGAGGGATTT TCTAGGGGCA 120
TGGGGGAGAG CTTCGTGGAG GAGGGGGTAT TTGTGGTGAC CACAAATGGA AAATGGAGCT 180
GGAGTTAGGG AAAAGGGGGT CTTGGCAAGA CAACAGCATG AGCAAAGGTA TGGAGAGGCA 240
AGAGAGAGAG AGCAAGGATG TCTTTAGGTC TAGAATGTGG GTAGCGGGGA AGTAGAGGAG 300
GCTCCCAGGC CAGGGTCAGG AGCTTGAATT TGAGCATGCG GTCTTTCATC ACTAGATAGC 360
TGTTCACCAG CAAAGACCCT TGCACCCTCC TCTGTGCCAG GCCAGCACCA GGACACAGAA 420
AAAAACAACA ACACAGGAAC CTAGCCCTAA GCCCTGATCC CTAGGAGGCC CTCAGGCTGG 480
TGGAGACAGA GCAAGATAAA GACACTCTAG CTCCATGGAG TCATGGCTGG ACCAGAGAGA 540
GGAACAGGGG GGAACGTTGG GGACAGAGAG GGGTGCCAGG GTGTTGTCTG GGGGGAGATG 600
CAGGAAAGCT GCCTGGAGGA GGGGACATTT TTACTGGGTT TTGAAGGATA AATAGGAGCT 660
CTTCCAAGTA AAAAAAAAGA ATAAGCCTGT AAACATTACC CCATGATAGG TCACAACTGG 720
ATTCATGAAT ATTGTATATA TATCTCTATA TATACACAGT GCTAGCTAAA CTTTCCTAGG 780
TAAATATCAT TATTCCCAAA TTAAAGACAG AAATACAGGG ACAGAGAGCC ATTAAGTGAC 840
TTATCTGAGG TCACACAGCG GCTAAGTGGG CGAGCTAGGG TTTGAACCCA GGCCATCTGG 900
GTCGAATTCT AGGCTCTTTT TTTTTTTTTT TTTTTTTTTT GAGACGGAGT CTTGCTCTGT 960
CGCCCAGGCT GGAGTGCAGT GGCTCGATCT CAGCTCACTG 1000
|
